Ben McPoland considers a pair of investments that are performing awfully in his ISA portfolio so far this year. What's gone ...

Despite a solid Q4 earnings beat, Edwards Lifesciences' shares remain undervalued with a reduced P/E multiple of 33x. Read ...

Smaller-cap AI stocks may present potentially attractive investment opportunities for investors seeking exposure beyond the ...

Investing in dividend growth stocks is a smart, reliable way to build passive income that lasts a lifetime, and it’s worth ...

Want to stay informed with market insights and investing ideas from Morningstar? Sign up for my weekly Smart Investor ...

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money ...

Find insight on BioNTech, PharmAla Biotech, Dentalcorp Holding and more in the latest Market Talks covering the Health Care ...

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes.

The key is to focus on companies with a strong competitive edge and a track record of growing earnings and cash flow.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Healthequity (HQY – Research Report) and Alnylam Pharma ...